抗病毒剂:作用的结构基础和合理设计
Luis Menéndez-Arias1, Federico Gago2
1Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid), Madrid, Spain. lmenendez@cbm.csic.es.
Sub-cellular biochemistry
|December 31, 2024
概括
基于计算机的方法加速了针对病毒蛋白和囊的新型抗病毒药物的发现. 这篇综述强调了基于结构的方法和成功的例子,如流感和艾滋病毒治疗.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 40年来,抗病毒药物开发取得了重大进展.
- 抗病毒点包括细胞内过程和细胞外病毒/囊.
- 肝炎C病毒 (HCV) 和人类免疫缺陷病毒 (HIV) 疗法是进展的例子.
研究的目的:
- 审查用于识别新型抗病毒药物的基于计算机的方法.
- 用具体的例子来说明基于结构的药物开发.
- 展示病毒囊体作为抗病毒治疗的可行的点.
主要方法:
- 专注于基于计算机的方法用于抗病毒药物发现.
- 基于结构的药物设计的示例.
- 审查现有的抗病毒药物及其作用机制.
主要成果:
- 基于结构的设计产生了神经氨基酶抑制剂 (流感) 和蛋白酶抑制剂 (HIV).
- 这些药物的例子包括oseltamivir,zanamivir和darunavir.
- 病毒囊是有效的点,正如乙型肝炎病毒 (HBV) 和艾滋病毒的药物所证明的那样.
结论:
- 基于计算机和基于结构的方法对于现代抗病毒药物发现至关重要.
- 向病毒囊是一种成功的治疗策略.
- 最近的批准,如lenacapavir,验证了这些方法.
相关概念视频
Structure-Activity Relationships and Drug Design
412
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
412
Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
Retrovirus Life Cycles
45.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.3K
Viral Structure
60.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
60.9K
Targets for Drug Action: Overview
5.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.8K
Immune Response Against Viral Pathogens
443
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
443


